Intracellular Th Stock Price on December 3, 2024
| ITCI Stock | USD 83.88 0.77 0.93% |
Below is the normalized historical share price chart for Intracellular Th extending back to December 27, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Intracellular stands at 83.88, as last reported on the 11th of December 2024, with the highest price reaching 84.18 and the lowest price hitting 81.37 during the day.
If you're considering investing in Intracellular Stock, it is important to understand the factors that can impact its price. Intracellular is very steady at the moment. Intracellular Th holds Efficiency (Sharpe) Ratio of 0.0902, which attests that the entity had a 0.0902% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Intracellular Th, which you can use to evaluate the volatility of the firm. Please check out Intracellular's Market Risk Adjusted Performance of 0.2528, risk adjusted performance of 0.0822, and Downside Deviation of 1.69 to validate if the risk estimate we provide is consistent with the expected return of 0.19%.
As of now, Intracellular's Other Stockholder Equity is increasing as compared to previous years. The Intracellular's current Stock Based Compensation is estimated to increase to about 55.5 M, while Total Stockholder Equity is projected to decrease to under 366.2 M. . The Intracellular's current Price Earnings To Growth Ratio is estimated to increase to 1.11, while Price To Sales Ratio is projected to decrease to 14.05. Intracellular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of January 2014 | 200 Day MA 74.0396 | 50 Day MA 81.506 | Beta 0.973 |
Intracellular |
Sharpe Ratio = 0.0902
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ITCI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.13 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Intracellular is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intracellular by adding it to a well-diversified portfolio.
Price Book 7.7677 | Enterprise Value Ebitda (37.12) | Price Sales 14.4897 | Shares Float 103.7 M | Wall Street Target Price 103.5 |
Intracellular Main Headline on 3rd of December 2024
Intra-Cellular Therapies Submits Supplemental New Drug Appli... by finance.yahoo.com
The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTAs robust antidepressant efficacy and favorable safety and tolerability profileCAPLYTA, if approved as an adjunctive therapy in MDD, would be indicated for the treatment of three different major psychiatry indications affecting over 30 million adult patients in the US BEDMINSTER, N.J., Dec. 03, 2024 -- Intra-Cellular Therapies, Inc. , a biopharmaceutical company focused o
Intracellular Valuation on December 3, 2024
It is possible to determine the worth of Intracellular on a given historical date. On December 3, 2024 Intracellular was worth 86.01 at the beginning of the trading date compared to the closed value of 85.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Intracellular stock. Still, in general, we apply an absolute valuation method to find Intracellular's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intracellular where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Intracellular's related companies.
| Open | High | Low | Close | Volume | |
| 85.53 | 86.99 | 85.39 | 86.03 | 466,633 | |
12/03/2024 | 86.01 | 86.76 | 84.47 | 85.31 | 346,203 |
| 85.00 | 86.32 | 84.73 | 85.95 | 427,281 |
| Backtest Intracellular | | | Intracellular History | | | Intracellular Valuation | Previous | Next |
Intracellular Trading Date Momentum on December 3, 2024
| On December 04 2024 Intracellular Th was traded for 85.95 at the closing time. The top price for the day was 86.32 and the lowest listed price was 84.73 . The trading volume for the day was 427.3 K. The trading history from December 4, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 0.75% . The trading delta at closing time against the current closing price is 2.22% . |
Intracellular Th Fundamentals Correlations and Trends
By evaluating Intracellular's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Intracellular's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Intracellular financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Intracellular Stock history
Intracellular investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intracellular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intracellular Th will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intracellular stock prices may prove useful in developing a viable investing in Intracellular
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 95.9 M | 55.1 M | |
| Net Loss | -230.6 M | -219.1 M |
Intracellular Quarterly Net Working Capital |
|
Intracellular Stock Technical Analysis
Intracellular technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Intracellular Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Intracellular Th cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Intracellular December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Intracellular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intracellular shares will generate the highest return on investment. By undertsting and applying Intracellular stock market strength indicators, traders can identify Intracellular Th entry and exit signals to maximize returns
Intracellular Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Intracellular's price direction in advance. Along with the technical and fundamental analysis of Intracellular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intracellular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0822 | |||
| Jensen Alpha | 0.1112 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.0566 | |||
| Treynor Ratio | 0.2428 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Intracellular Stock analysis
When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |